Michael C. Kaufmann, CEO, Pharmaceutical Segment at CARDINAL HEALTH INC (CAH), sold 58,662 shares at $44.95 ($2.6M) on 2013-01-23, disclosed to the SEC on 2013-01-25.
Scheduled sale ($2.6M) by CEO, Pharmaceutical Segment under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 300 | $0 | 0.0% |
| 2 | $44.95 | 58,362 | $2.6M | 100.0% |
| Total | $44.72 avg | 58,662 | $2.6M | 100% |
| Filing → |
| CAH | SELL | 2014-02-11 | $26.2M | — | Filing → |
| CAH | SELL | 2013-05-23 | $2K | — | Filing → |
| CAH | SELL | 2011-10-28 | $1.9M | — | Filing → |